CYTEGRITY Trademark

Trademark Overview

On Wednesday, January 6, 2016, a trademark application was filed for CYTEGRITY with the United States Patent and Trademark Office. The USPTO has given the CYTEGRITY trademark a serial number of 86867368. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Tuesday, May 28, 2024. This trademark is owned by Calimmune, Inc.. The CYTEGRITY trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Biomanufacturing for others, namely, manufacturing of pharmaceuticals and of viral vectors and gene therapy vectors

Scientific, pharmaceutical and medical research and development; biological research; laboratory services in connection with viral vectors and gene therapy vectors
cytegrity

General Information

Serial Number86867368
Word MarkCYTEGRITY
Filing DateWednesday, January 6, 2016
Status710 - CANCELLED - SECTION 8
Status DateTuesday, May 28, 2024
Registration Number5335997
Registration DateTuesday, November 14, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 13, 2016

Trademark Statements

Goods and ServicesBiomanufacturing for others, namely, manufacturing of pharmaceuticals and of viral vectors and gene therapy vectors
Goods and ServicesScientific, pharmaceutical and medical research and development; biological research; laboratory services in connection with viral vectors and gene therapy vectors

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateTuesday, May 28, 2024
Primary Code040
First Use Anywhere DateTuesday, August 25, 2015
First Use In Commerce DateTuesday, August 25, 2015
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateTuesday, May 28, 2024
Primary Code042
First Use Anywhere DateTuesday, August 25, 2015
First Use In Commerce DateTuesday, August 25, 2015

Trademark Owner History

Party NameCSL BEHRING GENE THERAPY, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressTUSCON, AZ 85711
Party NameCalimmune, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTucson, AZ 85711
Party NameCalimmune, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTucson, AZ 85711
Party NameCalimmune, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTucson, AZ 85711

Trademark Events

Event DateEvent Description
Thursday, April 21, 2016NON-FINAL ACTION WRITTEN
Saturday, January 9, 2016NEW APPLICATION ENTERED
Thursday, January 14, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 21, 2016ASSIGNED TO EXAMINER
Tuesday, December 13, 2016PUBLISHED FOR OPPOSITION
Thursday, April 21, 2016NON-FINAL ACTION E-MAILED
Thursday, April 21, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 3, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 14, 2016ASSIGNED TO LIE
Thursday, October 20, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 20, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 21, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 9, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 23, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 29, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 13, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 7, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 13, 2017TEAS STATEMENT OF USE RECEIVED
Monday, March 13, 2017USE AMENDMENT FILED
Friday, March 24, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 28, 2017STATEMENT OF USE PROCESSING COMPLETE
Friday, March 31, 2017NON-FINAL ACTION E-MAILED
Friday, March 31, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 31, 2017SU - NON-FINAL ACTION - WRITTEN
Thursday, October 12, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, October 13, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 14, 2017REGISTERED-PRINCIPAL REGISTER
Monday, November 14, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, October 25, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 25, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 2, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 2, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 4, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, October 25, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 25, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 28, 2024CANCELLED SEC. 8 (6-YR)
Wednesday, November 8, 2023WITHDRAWAL OF ATTORNEY GRANTED
Wednesday, October 25, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 8, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED

Related Keywords

cytegrity vectors gene research viral therapy biological development laboratory services connection